A tubeless, patch-pump automated insulin-delivery system — Insulet’s Omnipod 5 — was both safe and effective in a prospective study of kids and adults with type 1 diabetes.
Following a positive meeting with the FDA, Radius Health announced plans for its phase II/III SCOUT study for the company’s investigational treatment for Prader-Willi syndrome, RAD011, a synthetic cannabidiol oral solution.
In a head-to-head randomized trial comparing insulin pens with syringes, patients with diabetes saw a greater drop in HbA1c with pens but no differences in treatment adherence rates, hypoglycemia, need for greater insulin doses or oral medication, or progression to basal-bolus insulin scheme. (Diabetology & Metabolic Syndrome)
Good news for women with chronic hypoparathyroidism: most have perfectly normal pregnancy outcomes. Overall, the only increased risks in a recent study were for induction of labor and lower birth weight infants. (Journal of Clinical Endocrinology & Metabolism)
Rep. Marjorie Taylor Greene (R-Ga.) was suspended from Twitter for half a day after writing that COVID vaccinations should instead focus on “defeating obesity” and that COVID is “not dangerous” for people who are not obese or under the age of 65. (The Hill)
The investigational type 1 diabetes agent IMT-002 — a first-in-class, oral blocker of the HLA-DQ8 isoform — was deemed safe and tolerable in a phase Ib study, IM Therapeutics announced.
Ascensia Diabetes Care launched a new patient assistance program to lower out-of-pocket costs for its Eversense continuous glucose monitor.
Downing caffeine fast — 800 mg in 6 hours — increased renal calcium clearance by 77%, potentially increasing the risk for osteoporosis. (British Journal of Clinical Pharmacology)